receptors may at least partly contribute to these effects. Anyhow, these mechanisms differ from that underlying the ability of YM-14673 and TRH to elicit wet-dog shakes, a mechanism that is known to involve serotonergic processes.
Introduction
Thyrotropin-releasing hormone (TRH) has been shown to elicit a variety of biological activities in ani mals and man (Prasad, 1987; Yamamoto and Shimizu, 1987 Yamamoto et al., 1990; Matsui et al., 1994) . Many of these effects appear to share a common dopaminergic mechanism; for example, (a) potentiation of the behavioural effects of l-3,4-dihydroxy phenyl alanine (Plotnikoff et al., 1972) , (b) induction of ro ta tional behaviour in apomorphine-treated mice (Rips and Boschi, 1985) , and (c) activation of tyrosine hy droxylase (Yokoo et al., 1987) . F urtherm ore, it has been found th at inhibition of dopam ine recep tors attenuates T R H effects (Popoli et al., 1991) . In deed, dopam inergic term inal areas such as the nucleus accumbens receive a dense innervation of T R H -containing fibres (Johansson et al., 1983) and contain a high concentration of T R H receptors (Taylor and Burt, 1982) . The m echanism underlying T R H augm entation of dopam ine-dependent behaviours is still u n d er dis cussion. A p art from th e conflicting reports concerning the ability of T R H to enhance the release of dopam ine (Miyamoto et al., 1981; Sharp et al., 1982; Xu et al., 1990; M éndez et al., 1993) , it is also able to inhibit the uptake of dopam ine (Prasad, 1987 (Prasad, , 1991 277 (1995) [63] [64] [65] [66] [67] [68] [69] these properties may underlie the ability of T R H to alter dopam ine-dependent effects, it cannot underlie the wet-dog shakes th at are elicited by TR H , since 5-H T2a receptors appear to be involved in this T R H effect (Fone et al., 1989a) , Today, there are several T R H analogues th a t are known to produce T R H effects. Previously, we have shown that the T R H analogue, A^a-[{(5)-4-oxo-2-azetidinyI}-carbonyI]-L-histidyl-L-proIinamide dihydrate (YM-14673), elicits dopamine-like behaviours such as sniffing and hyperlocomotion (Yamamoto et al., 1990) . The goal of the present study was to investigate w hether YM-14673 is indeed able to elicit dopam ine-specific behaviour. For th at purpose, YM-14673 was injected into the nucleus accumbens, the ventrolateral striatum , and the dorsal striatum in order to study its ability to elicit dopamine-specific repetitive jaw movements. For a long time, it is known th at stim ulation of dopam ine D j and D 2 receptors in these brain regions can gener ate or m odulate such repetitive jaw m ovem ents (Koshikawa et al., , 1989 (Koshikawa et al., , 1990a Bordi and M eller, 1989; Kelley et al., 1988 Kelley et al., , 1989 Delfs and Kelley, 1990; Kikuchi de Beltrdn et al., 1992; Prinssen et al., 1992; K oene et al., 1993) . To study the specificity of the response of YM-14673, the ability of the dopam ine D j/D^ receptor antagonist c is-(Z )-flupentixol (Puech et al., 1981) and th e 5-H T2A recep tor antagonist IC I 169,369 (Blackburn et al., 1988) to attenuate the response of YM-14673 was analysed. Finally, YM-14673 was given intrathecally in o rd er to investigate w hether this T R H analogue can elicit wetdog shakes, a T R H effect that requires an enhanced serotonin activity at the level of 5-H T 2A receptors (Fone et a l, 1989a,b) .
Materials and methods

M easurem ent o f ja w m ovem ents
Surgical procedure M ale Sprague-Dawley rats (260-300 g) w ere anaes thetized w ith ketam ine H C 1 ( 1 0 m g /k g i.p.X supple m ented during surgery with halothane (0 .5 -4 % as ap propriate). T he surgical and recording procedures w ere as described previously (Koshikawa et al., 1989 (Koshikawa et al., ,1990a (Koshikawa et al., ,b, 1991 . A small light-em itting diode was fixed to the m andible and th e anim al was placed in a stereotactic fram e so th at the head was kept in constant relation to a light-sensitive transducer which detected th e vertical and horizontal m ovem ents of the diode. Bipolar elec trodes w ere placed into th e m asseter and digastric muscles to record electrom yographic (EM G ) activity. The spinal cord was transected at C l level to confine drug-induced jaw m ovem ents to the head region. T he
Nucleus accumbens
Dorsal striatum Ventrolateral striatum Fig. 1 . Injection sites in the nucleus accumbens, the dorsal striatum and the ventrolateral striatum. Planes are modified to a series of two or three sections for each brain area from the atlas of Paxinos and Watson (1986) ; approximate coordinates indicated are in mm ante rior to the interaural line.
jaw movements were recorded on a polygraph for later quantification and were counted autom atically with a spike trigger. Stainless steel guide cannulas (0,5 mm o.d., 0.3 mm i.d.) were im planted bilaterally into the nucleus accumbens (anterior = 1 0 .6 mm from interau ral line; lateral = 1.7 mm from m idline; vertical = 3.2 mm from interaural line), the dorsal striatum (anterior = 9.2 mm; lateral = 3.5 mm; vertical = 6.2 mm) or ven trolateral striatum (anterior = 8 . 6 mm; lateral = 4 mm; vertical = 3.5 mm), according to th e atlas o f Paxinos and W atson (1986) (Fig. 1) . T he nucleus accumbens cannulas were angled 2 0° from th e m id-sagittal plane to avoid the ventricular system. A fter surgery, the animals were m aintained under anaesthesia by contin uous infusion of ketam ine (10 m g /h i.v.), Lignocaine HC1 (2 %) gel was applied to all incisions and the rectal tem perature was m aintained at 37° C with a thermo statically controlled heating pad. M onitored concentra tions of expired 0 2 and C 0 2 during the experiment were 19-21% and 2.0-2.5% , respectively.
Behavioural observations
The num ber of jaw openings g rea te r th an 1 mm (measured from the diode displacem ent) was counted in consecutive 5 m in periods for 240 min according to our paradigms previously described (Koshikawa et at, 1991; Kikuchi de B eltran et al., 1992) . Jaw movements and EM G activity were also recorded on a polygraph for further analysis of the p attern of jaw movements (see also Koshikawa et al., 1991; K ikuchi de Beltran et al., 1992) .
YM-14673 (0.1 and 1 ¡¿g) was bilaterally injected into each brain structure. injections were made in 0 .2 /i 1 solution (per side) of a m ixture of the respective two drugs. The doses of the antagonists have previously been found to block effec tively apomorphine-induced jaw movements (Koshikawa et al., 1990b; Kikuchi de Beltran et aL, 1994) . Since YM-14673 produced responses th at could be attenuated by c/s-(Z)-flupentixol, it was decided to com pare the EM G pattern of YM-14673 with that of the combined administration of the dopam ine D x re ceptor agonist SKF 82958 (5 /xg) and the dopam ine D 2 receptor agonist quinpirole ( 1 0 ¿ig), a treatm ent known to elicit dopamine-specific, repetitive jaw movements (Koshikawa et al., 1991; Kikuchi de Beltran et al., 1992) . All drugs were dissolved in saline and injected bilaterally into the brain sites over 30 s in a volume of 0.2 jul, and the needle was left in situ for 30 s after drug injection.
Histology
A t the end of the experiments, the rats were deeply anaesthetized with sodium pentobarbitone, perfused transcardially with 1 0 % formaldehyde solution and the brains were removed. Injection sites were identified from 50 jim coronal sections stained with cresyl violet. The data were analysed only for those animals in which injections were correctly placed. Experimental groups consisted of six rats and animals were used only once.
M easurement o f wet-dog shakes
W et-dog shakes occurring in the individual male Sprague-Dawley rats were counted for consecutive 5 min periods during 90 min after intrathecal injection of YM-14673 or TRH . For the intrathecal injections, the rats w ere first anaesthetized with sodium pentobarbi tone (50 m g /k g i.p.) to allow a polyethylene catheter (8.5 cm length, 0.5 mm o.d.) to be im planted along the spinal subarachnoid space, so that the caudal tip of the catheter was at the thoraco-lumbar junction of the spinal cord (Yaksh and Rudy, 1976) . Animals were allowed 7 days to recover from surgery; rats showing m otor dysfunction were eliminated from the study. Subsequently, YM-14673 (0.5 fig) and T R H (0.5 ¡ig) w ere tested. The dose of TRH has previously been found to elicit wet-dog shakes (Fone et a l, 1989a) . Intrathecal injection was made over 30 s in a volume of 5 ¡i\ followed by 5 til saline for washing.
Drugs
The drugs used were YM-14673 ( N a-[{(S)-4-oxo-2~ azetidinyl}-carbonyl]-L-histidyl-L-prolinam ide dihy drate, Yamanouchi Pharmaceutical Co.), thyrotropinreleasing hormone (TRH, Peptide Institute), SKF 38393 hydrochloride (l-phenyl-2,3,4,5-tetrahydro-l#-3-benzazepine-7,8-diol hydrochloride, R esearch Biochemicals International), quinpirole hydrochloride (R esearch Biochemicals International), cw -iZM lupentixol dihy drochloride (Lundbeck) and ICI 169,369 (2-(2-dimethylam inoethylthio)-3-phenylquinoline hydrochloride, ICI Pharm aceuticals).
Statistical analysis
All values are expressed as m eans ± S.E.M. Timecourse data w ere statistically analysed with a two-way rep eated analysis of variance (A N O V A ) followed by a Newm an-Keuls m ultiple com parison test. Total jaw m ovem ents d ata w ere analysed with a one-way A N O V A followed by a Newman-Keuls test. D ifferences were considered significant when P < 0.05.
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Results A
E ffects o f YM -14673 or TR H injection into the nucleus accum bens on jaw movements
Bilateral injection of YM-14673 (0.1 and 1 (Mg/02 jicl per side) dose-dependently elicited repetitive jaw movements. T he effects of YM-14673 reached maxi mum level at 2 0 min after injection and rem ained stable until at least 4 h after injection (Fig. 2A) . F or sake of comparison, YM-14673 was also given into the ventrolateral or dorsal region of th e striatum . YM-14673 (0.1 and 1 ¡ig) injected into th e dorsal striatum elicited repetitive jaw movements, b u t the effect was smaller and slower in onset (the effect reached m axi mum at 60 min after injection , Fig, 2B) ; th e sm allest effect with slowest onset was found, when the com pound was given into th e ventrolateral striatum : the effect reached maximum at 150 m in after injection (Fig. 2C ). In contrast, T R H (1 jug and 10 fig /0.2 fil) failed to evoke any effect (Fig. 3) ; even a dose of 30 fig TRH rem ained ineffective, when injected into th e n u cleus accumbens (data n o t shown). the production of jaw movements induced by YM-14673 (P < 0.01 for the nucleus accumbens; P < 0.05 for the dorsal striatum, Newman-Keuls test) (Fig. 4) .
3.2, E ffects o f cis-(Z)-flupentixol on ja w m ovem ents in duced by YM -14673 injected into the nucleus accum bens
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5,5. Effects oflCI 169,369 on jaw m ovem ents induced by YM-14673 injected into the nucleus accumbens or dorsal striatum
ICI 169,369 into the nucleus accum bens or the dor sal striatum failed to affect the jaw movements induced by YM-14673 (Fig. 5) .
The pattern o f jaw m ovem ents including EMG changes induced by YM-14673 and th e combination of SK F 82958 and auinnirole
T he pattern of jaw movements occurring after ad ministration of YM-14673 (1 fig) into the nucleus ac cumbens is illustrated in Fig. 6 , T h e u p p er traces show th e jaw movements m ade in the vertical and horizontal direction, whereas the lower traces show the EMG recordings of the m. digastricus (jaw-opening muscle) and m. masseter (jaw-closing muscle), respectively. It can be seen that YM-14673 produced large amplitude parison with the form er. Jaw m ovem ents in the hori zontal direction (lateral jaw m ovem ents) were also present. T he jaw movements w ere associated with a pronounced activity of the digastric muscle and the m asseter muscle. The m ovem ents w ere not accompa nied by tongue protrusions. This p attern differed from that produced by injections of the dopam ine and D 2 recep to r agonists com bination (SKF 82958 5 ¿¿g-f quinpirole 1 0 ¡xg / 0 . 2 ¿¿,1) into the nucleus accumbens. This com bination produced a continuous series of opening and closing movements of jaw with varying am plitude. D igastric and m asseter muscles showed continuous activity throughout the period of maximum drug effect (Fig. 6 ). F requent tongue protrusions oc curred during the large am plitude jaw openings. This p attern was similar to that described previously (Koshikawa et al.3 1991; Kikuchi de Beltran et al., 1992) . Y. Miwa et af. / European Journal o f Pharmacology 211 (1995) 63-69 
Y, Miwa et a i /E u ro p ea n Journal o f Pharmacology 277 (1995) 63-69
E ffects o f YM-14673 or TR H on wet-dog shakes induced by intrathecal injection
Intrathecal injection of both YM-14673 (0.5 fig) and TR H (0.5 jig) elicited wet-dog shakes: the effect of YM-14673 was greater and longer lasting than that of TRH (Fig. 7) .
Discussion
YM-14673 injected into th e nucleus accumbens, dorsal striatum or ventrolateral striatum elicited re p e t itive jaw movements in a dose-related m anner. T he response to accumbens injections was the greatest, whereas that to injections into the ventrolateral stria tum was the smallest. These findings exclude the possi bility th at YM-14673 diffused from the nucleus accum bens to th e dorsal striatum, or vice versa. Thus, it can be concluded that both th e nucleus accumbens and the dorsal striatum play a role in jaw movements elicited by YM-14673, Since the response of YM-14673 was (Fig. 6 )* A lthough the differences in number and am plitude of jaw move ments may have resulted from differences in the d e gree in which the dopaminergic postsynaptic activity is altered by uptake inhibition (YM-14673) and direct receptor stimulation (SKF 82958 + quinpirole), the ab sence (YM-14673) or presence (SKF 82958 + quinpirole) of tongue protrusions cannot be ascribed to such differences. Secondly, YM-14673 was nearly in ef fective after injections into the ventrolateral striatum , but reasonably effective after injections into the dorsal striatum (Fig. 3) . In contrast, stim ulation of dopam ine D x and D 2 receptors is m ost effective after injections into the ventrolateral striatum , but ineffective after injections into the dorsal striatum 1 (Koshikawa et aL, 1989) . Finally, the effects of YM-14673 could be blocked only partially by a dose of the dopamine D l/ D 2 receptor antagonist cis-(Z)-flupentixol that is highly effective in blocking the effects of dopam ine receptor agonists upon jaw movements (Koshikawa et aL, 1990b) . These data together strongly suggest th at YM-14673 has additional effects, apart from those upon the dopam ine transmission. The finding that YM-14673 like T R H elicits wet-dog shakes underscores this con clusion, since TR H -induced wet-dog shakes appear to need an enhanced serotonin activity (Fone et aL, 1989a,b) . However, the present study excludes the pos sibility that changes in the serotonin transmission con tribute to the effect of YM-14673 upon jaw move ments, since the 5-HT2A receptor antagonist remained devoid of any effect. The finding that T R H itself was unable to elicit jaw movements is difficult to understand. Since TRH is m ore susceptible to peptidases than YM-14673 (Grif fiths et aL, 1980; N akam ura et aL, 1991) , it can be speculated that T R H was too rapidly metabolized in the brain structures under study in order to stimulate sufficiently the receptors involved.
Taking the above-m entioned findings and considera tions together, it appears that the TRH analogue YM-14673 can induce its behavioural effects by at least two different mechanisms. First, it can stimulate TRH re ceptors and, consequently, produces wet-dog shakes involving alterations in the serotonin transmission. Second, it can directly a n d /o r indirectly enhance the dopam ine activity at the level of dopamine D j / D 2 receptors in certain brain structures. Although the latter mechanism may at least partly contribute to the ability of YM-14673 to elicit jaw movements after in jections into the nucleus accumbens, the dorsal stria tum and, possibly, the ventrolateral striatum, it is evi dent that additional mechanisms must play a role in th e display of jaw movements.
